WithdrawnNot applicableNCT00638625

Correlation of X-ray and Pathology With Needle Biopsy of Lung Tumors

The purpose of this study is to compare the features that the pathologist sees, when examining a lung tumor under the microscope, to the way that the tumor appears on the computed tomography (CT) scan. Features of the tumor may include abnormal blood vessels and areas in which tumor cells are dying. The samples that are taken during the needle biopsy contain information from one small part of the tumor. The investigators believe that they can show where in the tumor the samples came from, based on the CT scans during the biopsy procedure. If the investigators can accurately determine where in the tumor their samples came from, they can compare the features of that part of the tumor, as seen on the CT images, to the features of that part of the tumor as seen under the microscope. This research study also will give the investigators an idea of how much the biopsy samples are distorted in the process of preparing them for examination under the microscope.

Checked against the public recordLast updated May 14, 2015 · Source: ClinicalTrials.gov

StatusWithdrawn
PhaseNot applicable
U.S. locations1
SponsorState University of New York - Upstate Medical University
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
State University of New York - Upstate Medical University
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Subjects who have a lung tumor that is likely to be malignant * Subjects who have been referred for percutaneous needle biopsy * The target lesion must be at least 10 mm in short-axis dimension. * Subjects must have intravenous access. * No history of significant allergy to intravenous contrast. * Subjects must have sufficient renal function to receive intravenous contrast for enhancement of the CT images. Exclusion Criteria: * Vulnerable populations will be excluded. * Subjects who lack the capacity to provide consent * Subjects who are pregnant

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • SUNY Upstate Medical UniversitySyracuse, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 14, 2015. Always confirm current availability with the study team.

View original record ↗